世界の核酸遺伝子治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Nucleic-Acid Based Gene Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12519 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、核酸遺伝子治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。核酸遺伝子治療の種類別市場規模（DNA、RNA）、用途別市場規模（学術・政府研究所、製薬・バイオテクノロジー企業、委託研究機関、病院・診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・核酸遺伝子治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Wave Life Sciences、Phylogica、Benitec Biopharma、Celsion、Copernicus Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：DNA、RNA ・用途別分析2016年-2026年：学術・政府研究所、製薬・バイオテクノロジー企業、委託研究機関、病院・診断センター、その他 ・核酸遺伝子治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・核酸遺伝子治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・核酸遺伝子治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・核酸遺伝子治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・核酸遺伝子治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Nucleic-Acid Based Gene Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nucleic-Acid Based Gene Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Nucleic-Acid Based Gene Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Nucleic-Acid Based Gene Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
DNA
RNA

Market segment by Application, can be divided into
Academic and Government Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Hospitals and Diagnostic Centers
Others

Market segment by players, this report covers
Wave Life Sciences
Phylogica
Benitec Biopharma
Celsion
Copernicus Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Nucleic-Acid Based Gene Therapeutics
1.2 Classification of Nucleic-Acid Based Gene Therapeutics by Type
1.2.1 Overview: Global Nucleic-Acid Based Gene Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Type in 2020
1.2.3 DNA
1.2.4 RNA
1.3 Global Nucleic-Acid Based Gene Therapeutics Market by Application
1.3.1 Overview: Global Nucleic-Acid Based Gene Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Academic and Government Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Contract Research Organizations
1.3.5 Hospitals and Diagnostic Centers
1.3.6 Others
1.4 Global Nucleic-Acid Based Gene Therapeutics Market Size & Forecast
1.5 Global Nucleic-Acid Based Gene Therapeutics Market Size and Forecast by Region
1.5.1 Global Nucleic-Acid Based Gene Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Nucleic-Acid Based Gene Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Nucleic-Acid Based Gene Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Nucleic-Acid Based Gene Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Nucleic-Acid Based Gene Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Nucleic-Acid Based Gene Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Nucleic-Acid Based Gene Therapeutics Market Drivers
1.6.2 Nucleic-Acid Based Gene Therapeutics Market Restraints
1.6.3 Nucleic-Acid Based Gene Therapeutics Trends Analysis
2 Company Profiles
2.1 Wave Life Sciences
2.1.1 Wave Life Sciences Details
2.1.2 Wave Life Sciences Major Business
2.1.3 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Product and Solutions
2.1.4 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Wave Life Sciences Recent Developments and Future Plans
2.2 Phylogica
2.2.1 Phylogica Details
2.2.2 Phylogica Major Business
2.2.3 Phylogica Nucleic-Acid Based Gene Therapeutics Product and Solutions
2.2.4 Phylogica Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Phylogica Recent Developments and Future Plans
2.3 Benitec Biopharma
2.3.1 Benitec Biopharma Details
2.3.2 Benitec Biopharma Major Business
2.3.3 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Product and Solutions
2.3.4 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Benitec Biopharma Recent Developments and Future Plans
2.4 Celsion
2.4.1 Celsion Details
2.4.2 Celsion Major Business
2.4.3 Celsion Nucleic-Acid Based Gene Therapeutics Product and Solutions
2.4.4 Celsion Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Celsion Recent Developments and Future Plans
2.5 Copernicus Therapeutics
2.5.1 Copernicus Therapeutics Details
2.5.2 Copernicus Therapeutics Major Business
2.5.3 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Product and Solutions
2.5.4 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Copernicus Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Nucleic-Acid Based Gene Therapeutics Players Market Share
3.2.2 Top 10 Nucleic-Acid Based Gene Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Nucleic-Acid Based Gene Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Nucleic-Acid Based Gene Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Nucleic-Acid Based Gene Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2026)
6.2 North America Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2026)
6.3 North America Nucleic-Acid Based Gene Therapeutics Market Size by Country
6.3.1 North America Nucleic-Acid Based Gene Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2026)
7.2 Europe Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2026)
7.3 Europe Nucleic-Acid Based Gene Therapeutics Market Size by Country
7.3.1 Europe Nucleic-Acid Based Gene Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Market Size by Region
8.3.1 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Region (2016-2026)
8.3.2 China Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2026)
9.2 South America Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2026)
9.3 South America Nucleic-Acid Based Gene Therapeutics Market Size by Country
9.3.1 South America Nucleic-Acid Based Gene Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size by Country
10.3.1 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Nucleic-Acid Based Gene Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Nucleic-Acid Based Gene Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Nucleic-Acid Based Gene Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Wave Life Sciences Corporate Information, Head Office, and Major Competitors
Table 7. Wave Life Sciences Major Business
Table 8. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 9. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Phylogica Corporate Information, Head Office, and Major Competitors
Table 11. Phylogica Major Business
Table 12. Phylogica Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 13. Phylogica Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Benitec Biopharma Corporate Information, Head Office, and Major Competitors
Table 15. Benitec Biopharma Major Business
Table 16. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 17. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Celsion Corporate Information, Head Office, and Major Competitors
Table 19. Celsion Major Business
Table 20. Celsion Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 21. Celsion Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Copernicus Therapeutics Corporate Information, Head Office, and Major Competitors
Table 23. Copernicus Therapeutics Major Business
Table 24. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 25. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 27. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Players (2019-2021)
Table 28. Breakdown of Nucleic-Acid Based Gene Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Nucleic-Acid Based Gene Therapeutics Players Head Office, Products and Services Provided
Table 30. Nucleic-Acid Based Gene Therapeutics Mergers & Acquisitions in the Past Five Years
Table 31. Nucleic-Acid Based Gene Therapeutics New Entrants and Expansion Plans
Table 32. Global Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 33. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Type (2016-2021)
Table 34. Global Nucleic-Acid Based Gene Therapeutics Revenue Forecast by Type (2021-2026)
Table 35. Global Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2021)
Table 36. Global Nucleic-Acid Based Gene Therapeutics Revenue Forecast by Application (2021-2026)
Table 37. North America Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Nucleic-Acid Based Gene Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Nucleic-Acid Based Gene Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Nucleic-Acid Based Gene Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Nucleic-Acid Based Gene Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Nucleic-Acid Based Gene Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Nucleic-Acid Based Gene Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Nucleic-Acid Based Gene Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Nucleic-Acid Based Gene Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Nucleic-Acid Based Gene Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Nucleic-Acid Based Gene Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Nucleic-Acid Based Gene Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Nucleic-Acid Based Gene Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Nucleic-Acid Based Gene Therapeutics Picture
Figure 2. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Type in 2020
Figure 3. DNA
Figure 4. RNA
Figure 5. Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Application in 2020
Figure 6. Academic and Government Research Institutes Picture
Figure 7. Pharmaceutical and Biotechnology Companies Picture
Figure 8. Contract Research Organizations Picture
Figure 9. Hospitals and Diagnostic Centers Picture
Figure 10. Others Picture
Figure 11. Global Nucleic-Acid Based Gene Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Nucleic-Acid Based Gene Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Region (2016-2026)
Figure 14. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Region in 2020
Figure 15. North America Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Nucleic-Acid Based Gene Therapeutics Market Drivers
Figure 21. Nucleic-Acid Based Gene Therapeutics Market Restraints
Figure 22. Nucleic-Acid Based Gene Therapeutics Market Trends
Figure 23. Wave Life Sciences Recent Developments and Future Plans
Figure 24. Phylogica Recent Developments and Future Plans
Figure 25. Benitec Biopharma Recent Developments and Future Plans
Figure 26. Celsion Recent Developments and Future Plans
Figure 27. Copernicus Therapeutics Recent Developments and Future Plans
Figure 28. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Players in 2020
Figure 29. Nucleic-Acid Based Gene Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Nucleic-Acid Based Gene Therapeutics Revenue Market Share in 2020
Figure 31. Global Top 10 Players Nucleic-Acid Based Gene Therapeutics Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Type in 2020
Figure 34. Global Nucleic-Acid Based Gene Therapeutics Market Share Forecast by Type (2021-2026)
Figure 35. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Application in 2020
Figure 36. Global Nucleic-Acid Based Gene Therapeutics Market Share Forecast by Application (2021-2026)
Figure 37. North America Nucleic-Acid Based Gene Therapeutics Sales Market Share by Type (2016-2026)
Figure 38. North America Nucleic-Acid Based Gene Therapeutics Sales Market Share by Application (2016-2026)
Figure 39. North America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Country (2016-2026)
Figure 40. United States Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Nucleic-Acid Based Gene Therapeutics Sales Market Share by Type (2016-2026)
Figure 44. Europe Nucleic-Acid Based Gene Therapeutics Sales Market Share by Application (2016-2026)
Figure 45. Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Country (2016-2026)
Figure 46. Germany Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Region (2016-2026)
Figure 54. China Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Nucleic-Acid Based Gene Therapeutics Sales Market Share by Type (2016-2026)
Figure 61. South America Nucleic-Acid Based Gene Therapeutics Sales Market Share by Application (2016-2026)
Figure 62. South America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source

---